Publication | Closed Access
Silibinin Inhibit Cell Migration through Downregulation of RAC1 Gene Expression in Highly Metastatic Breast Cancer Cell Line
18
Citations
15
References
2020
Year
In conclusion, the results demonstrate that the silibinin can be used as an experimental therapeutic for the management of TNBC metastatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1